BG60256B2 - Рекомбинантен метод за получаване на лимфотоксин - Google Patents

Рекомбинантен метод за получаване на лимфотоксин Download PDF

Info

Publication number
BG60256B2
BG60256B2 BG70460A BG7046085A BG60256B2 BG 60256 B2 BG60256 B2 BG 60256B2 BG 70460 A BG70460 A BG 70460A BG 7046085 A BG7046085 A BG 7046085A BG 60256 B2 BG60256 B2 BG 60256B2
Authority
BG
Bulgaria
Prior art keywords
lymphotoxin
dna
sequence
amino acid
nucleic acid
Prior art date
Application number
BG70460A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG60256B1 (bg
Inventor
Bharat Aggarwal
Timothy BRINGMAN
Patrick Gray
Glenn Nedwin
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of BG60256B1 publication Critical patent/BG60256B1/bg
Publication of BG60256B2 publication Critical patent/BG60256B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BG70460A 1984-05-31 1985-05-30 Рекомбинантен метод за получаване на лимфотоксин BG60256B2 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (2)

Publication Number Publication Date
BG60256B1 BG60256B1 (bg) 1994-03-24
BG60256B2 true BG60256B2 (bg) 1994-03-24

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
BG70460A BG60256B2 (bg) 1984-05-31 1985-05-30 Рекомбинантен метод за получаване на лимфотоксин

Country Status (23)

Country Link
EP (2) EP0164965B1 (member.php)
JP (3) JP2521703B2 (member.php)
AR (1) AR245219A1 (member.php)
AT (2) ATE95243T1 (member.php)
AU (1) AU599303B2 (member.php)
BG (1) BG60256B2 (member.php)
CA (1) CA1340641C (member.php)
CZ (1) CZ283148B6 (member.php)
DE (2) DE3587597T2 (member.php)
DK (1) DK171531B1 (member.php)
ES (1) ES8802182A1 (member.php)
FI (1) FI93025C (member.php)
GR (1) GR851317B (member.php)
HU (1) HU204085B (member.php)
IE (1) IE63487B1 (member.php)
IL (1) IL75318A (member.php)
NO (1) NO179075C (member.php)
NZ (1) NZ212207A (member.php)
PL (1) PL155410B1 (member.php)
PT (1) PT80573B (member.php)
RO (1) RO100383A2 (member.php)
SK (1) SK278333B6 (member.php)
YU (1) YU47735B (member.php)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62552A0 (en) 1980-04-03 1981-06-29 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
JP2557053B2 (ja) * 1984-12-21 1996-11-27 バイオジェン インコーポレイテッド 腫瘍壊死因子の精製、製造および使用法
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
EP0230781B1 (en) * 1985-12-24 1992-07-22 Denki Kagaku Kogyo Kabushiki Kaisha Lymphotoxin gene, method for its production, and lymphotoxin
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
JP4231106B2 (ja) * 1995-01-23 2009-02-25 ゼノテック インコーポレイティッド 骨溶解および転移を改善する方法
US5925351A (en) * 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
EP1045906B1 (en) 1998-01-15 2008-10-15 Genentech, Inc. Apo-2 ligand
JP2011516026A (ja) * 2002-11-26 2011-05-26 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための組成物と方法
CA2529945A1 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
US20050266004A1 (en) * 2003-12-08 2005-12-01 Jill Giles-Komar Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
WO2005092927A1 (en) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Receptor coupling agents and therapeutic uses thereof
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
MX2009003774A (es) * 2006-10-12 2009-04-22 Genentech Inc Anticuerpos para linfotoxina-alfa.
JP2010506955A (ja) 2006-10-20 2010-03-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド 可溶性リンホトキシンβレセプターによる脱髄障害の処置
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
EP3689362A1 (en) * 2014-04-25 2020-08-05 Naurex, Inc. Stable compositions of neuroactive peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88257I2 (member.php) * 1978-12-22 1994-02-03
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
IL75318A (en) 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production

Also Published As

Publication number Publication date
FI852143A0 (fi) 1985-05-29
NZ212207A (en) 1991-07-26
JP2804237B2 (ja) 1998-09-24
JP2521703B2 (ja) 1996-08-07
IE851321L (en) 1985-11-30
PT80573A (en) 1985-06-01
EP0164965A2 (en) 1985-12-18
JPH07250692A (ja) 1995-10-03
JPS6156197A (ja) 1986-03-20
IL75318A0 (en) 1985-09-29
NO179075B (no) 1996-04-22
RO100383A2 (ro) 1991-10-17
ES543695A0 (es) 1988-04-16
ATE95243T1 (de) 1993-10-15
FI93025B (fi) 1994-10-31
SK393085A3 (en) 1996-11-06
FI852143L (fi) 1985-12-01
SK278333B6 (en) 1996-11-06
YU47735B (sh) 1996-01-08
IE930589L (en) 1985-11-30
CZ283148B6 (cs) 1998-01-14
JPH07291995A (ja) 1995-11-07
YU91985A (en) 1988-12-31
EP0509553A1 (en) 1992-10-21
HU204085B (en) 1991-11-28
AU599303B2 (en) 1990-07-19
FI93025C (fi) 1995-02-10
DK241385D0 (da) 1985-05-30
GR851317B (member.php) 1985-11-25
PL253739A1 (en) 1986-03-11
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
RO100383B1 (ro) 1991-03-01
IL75318A (en) 1994-08-26
PT80573B (pt) 1987-08-19
DE3587597T2 (de) 1994-06-01
EP0509553B1 (en) 2000-08-09
DE3587597D1 (de) 1993-11-04
DE3588225T2 (de) 2001-04-05
ES8802182A1 (es) 1988-04-16
ATE195323T1 (de) 2000-08-15
AR245219A1 (es) 1993-12-30
PL155410B1 (en) 1991-11-29
CZ393085A3 (en) 1997-07-16
CA1340641C (en) 1999-07-13
NO179075C (no) 1996-07-31
NO852173L (no) 1985-12-02
EP0164965A3 (en) 1988-04-06
DE3588225D1 (de) 2000-09-14
DK171531B1 (da) 1996-12-23
DK241385A (da) 1985-12-01
IE63487B1 (en) 1995-05-03
HUT37814A (en) 1986-02-28
EP0164965B1 (en) 1993-09-29

Similar Documents

Publication Publication Date Title
BG60256B2 (bg) Рекомбинантен метод за получаване на лимфотоксин
JP2614989B2 (ja) 腫瘍壊死因子含有組成物
US4650674A (en) Synergistic cytotoxic composition
US7964712B2 (en) Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains
EP0499161A2 (en) GM-CSF inhibiting antibodies
US5683688A (en) Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6686455B1 (en) Tumor necrosis factor
DK172382B1 (da) Rekombinante lymphotoxinderivater
NZ226980A (en) Lymphotoxin-neutralising antibody and its use in separating out lymphotoxin from a composition
HK1070077B (en) Chimeric tnf ligands
IL104297A (en) Lymphotoxin Nucleic acid encoding vectors containing the nucleic acid and cells converted by them Methods for obtaining lymphotoxin